Endothelin-1, in particular, has been demonstrated in prostatic tissue in vivo and in human PC lines in vitro with plasma ET-1 concentrations significantly elevated in men with metastatic disease (Nelson et al, 1995). The gene discussed is EDN1; the disease is metastatic neoplasm.